India’s Cabinet Committee on Economic Affairs chaired by the Prime Minister Narendra Modi has given its approval for Industry-Academia Collaborative Mission for accelerating discovery research to early development for biopharmaceuticals. Named as “Innovate in India, empowering biotech entrepreneurs & accelerating inclusive innovation”, it will be funded by the government of India.
The Mission will be implemented by Biotechnology Industry Research Assistance Council (BIRAC) – a Public Sector Undertaking of Department of Biotechnology (DBT). The Mission Programme would be a Pan-India program. The key focus areas of the program would aid in preparing India’s technological and product development capabilities in the biopharmaceutical sector to a level that it is globally competitive over the next 10-15 years.
It will transform the health standards of India’s population through affordable product development. Total project cost to be funded by Government of India is Rs. 1500 crore for five years. 50% cost for the Mission Programme will be arranged through the World Bank loan. For the implementation, a Programme Management Unit will be set up at BIRAC which will work as an operational and functional arm that will monitor program’s implementation and progress.
Title
Collaborative mission for biopharmaceuticals
VATIS UPDATE Part
Article body
Source
